Status:
UNKNOWN
Embolic Stroke of Undetermined Source, Continuous Electrocardiography and Transthoracic ECHOcardiography in Hospitalized Patients With Ischemic Stroke
Lead Sponsor:
Herlev and Gentofte Hospital
Conditions:
Embolic Stroke of Undetermined Source
Eligibility:
All Genders
18+ years
Brief Summary
Transthoracic echocardiography (TTE) is recommended in patients with ischemic stroke when cardiac etiology is suspected to help plan secondary stroke management. However, discrepancy for specific clin...
Eligibility Criteria
Inclusion
- Hospitalized patients with verified acute ischemic stroke determined by magnetic resonance imaging (MRI) and/or computed tomography (CT) of cerebrum.
- Patients, regardless of age, in sinus rhythm with acute IS and potential cardioembolic stroke or cryptogenic stroke (CS/ESUS) according to Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria.
Exclusion
- Persons not able to cooperate.
- Persons unable to understand and sign "informed concent."
Key Trial Info
Start Date :
November 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 27 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04808258
Start Date
November 27 2020
End Date
March 27 2022
Last Update
March 22 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiology, Herlev & Gentofte Hospital
Copenhagen, Herlev, Denmark, 2730
2
Department of Neurology, Herlev & Gentofte Hospital
Copenhagen, Herlev, Denmark, 2730